Emergency War Surgery NATO Handbook: Part III: General Considerations of Wound
Management: Chapter XV: Anesthesia and Analgesia
Maintenance of Anesthesia
United States Department of Defense
Inhalation Agents. These agents have the advantage of being relatively easy to
titrate, thereby facilitating changes in anesthetic depth. There is a considerable body of
experience in the use of inhalation anesthetics in trauma surgery. Halothane was used to a
great extent during the Vietnam conflict. However, one must remember that all potent
halogenated agents depress the respiratory and cardiovascular systems and that such
effects are even more pronounced in the presence of hypovolemia. Often sub-minimal
alveolar concentration (MAC) dosages are adequate to provide analgesia and amnesia in the
critically injured casualty. Of the potent halogenated agents in current usage, isoflurane
appears to offer the advantages of very limited metabolism and a lesser degree of cardiac
depression than halothane or enflurane. These three halogenated drugs are potent
bronchodilators and therefore are useful in the asthmatic patient.
Isoflurane has a MAC of 1.15 in oxygen; 0.5 in 70% nitrous oxide. Inspired levels must
be maintained at 40% higher than MAC. For induction, one should use inspired gas
concentrations 3-4 times the maintenance. This drug is a potent respiratory depressant,
decreases peripheral vascular resistance, produces hypotension with little cardiovascular
depression, can cause malignant hyperthermia, has good muscle relaxant properties, and
allows rapid recovery due to low solubility. Nitrous oxide is usually safe, provided
adequate oxygen is administered. Therefore, an in-line oxygen analyzer should be used in
the circuit when nitrous oxide is given. The tendency for nitrous oxide to expand in any
closed space in the body (eg., pneumothorax, pneumocephalus, bowel obstruction) should
also be kept in mind. Although diethyl ether has had widespread use as a battlefield
anesthetic in the past, its flammability and lack of familiarity to most recently-trained
anesthetists make it a less attractive choice. Cyclopropane, in addition to being highly
explosive, is, like diethyl ether, no longer in common use and neither one should be used
in modern combat anesthesia.
Intravenous Agents. Narcotics, such as fentanyl and morphine, are good
analgesics and in adequate dosage are effective in blocking autonomic reflexes generated
by noxious stimuli during operations. The combined use of nitrous oxide, muscle relaxants,
and amnestics in a balanced anesthetic regime produces a "complete" anesthetic.
Although considerably less depressant than the potent inhalation agents, narcotics should
be carefully titrated in the unstable patient.
Fentanyl is a short-acting narcotic. One hundred mcg (2 ml) is equivalent to 10 mg of
morphine. This drug may be given as intermittent bolus injection of 1-2 mcg/kg or as a
continuous infusion of 2-50 mcg/min as titrated against blood pressure, pulse, or evidence
of reaction to pain. Side effects of fentanyl include respiratory depression, bradycardia,
bronchoconstriction, vomiting, and muscle stiffness. The muscle stiffness may need to be
treated by intravenous muscle relaxant& Fentanyl has minimal effect on blood pressure.
Newer agents, such as sufentanil and alfentanil, in conjunction with short-acting
muscle relaxants, may provide effective shortduration anesthesia and be successfully used
in outpatient surgical procedures. These can be especially useful when recovery ward or
ICU staffing is limited. The newer agonist-antagonist type of opiate drugs, such as
nalbuphine. and butorphanol, have also proved to be effective trauma anesthetics.
Ketamine is an effective analgesic and dissociative maintenance agent which can be used
either in incremental doses or as a continuous infusion. To prevent recall in a lightly
anesthetized patient, anterograde amnesia can be induced with scopolamine or small doses
of a benzodiazepine.
After an intravenous dose of 1-2 mg/kg rapid induction of anesthesia (within 30
seconds), an intense analgesia is produced. An endotracheal tube may not be required, but
one must remember that respiratory depression, apnea, coughing, and laryngospasm are
possible at any time. Ketamine produces increased salivation and tracheal secretions, and
can cause unwanted tachycardia, hypertension, increase in intraocular and intracranial
pressures, and eye movements.
This is an effective drug for treating bronchospasm that. is resistant to commonly used
bronchodilators. It is an excellent agent for induction of anesthesia in the asthmatic.
Ketamine's intense analgesia makes it useful in the treatment of the bum patient for
repeated debridement and dressing changes.
Postoperative excitement and dysphoria, which is produced at times by this drug, may be
minimized by using lower dosages or giving small amounts of benzodiazepines in combination
with ketamine. A continuous infusion can be used to reduce the total dose required for an
anesthetic. A solution of 1 mg/ml can be infused at a rate of 1-25 ml/min. A loading dose
of 50 mg should be used in the adult.
Midazalam, a new short-acting benzodiazepine, is probably the intravenous agent of
choice to reduce ketamine emergence' reactions.
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
This web version is provided by
The Brookside Associates Medical
Education Division. It contains original contents from the official US
Navy NAVMED P-5139, but has been reformatted for web access and includes
advertising and links that were not present in the original version. This web
version has not been approved by the Department of the Navy or the Department of
Defense. The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · ·
Other Brookside Products
|